Join the club for FREE to access the whole archive and other member benefits.

Alejandro Ocampo

Assistant Professor at University of Lausanne

Alejandro Ocampo obtained his PhD in 2012 from the University of Miami for his work under the supervision of Antoni Barrientos on the role of mitochondria in neurodegenerative proteinopathies and aging. Between 2013 and 2017, he performed a post-doctoral training with Juan Carlos Izpisua-Belmonte at the Salk Institute for Biological Studies in La Jolla, California. During his post-doctoral training at the Salk, he developed a novel technology to prevent the transmission of mitochondrial diseases and demonstrated the amelioration of age-associated hallmarks by partial cellular reprogramming. In August 2018, he joined the Department of Pharmacology and Toxicology as Assistant Professor and will continue his work on aging, cellular reprogramming and mitochondrial diseases.

Visit website: https://www.ocampolab.com/

 alejandro-ocampo-46678539

 OcampoLab

See also: Academia University of Lausanne (UNIL) - Public research university.

Details last updated 11-Feb-2021

Alejandro Ocampo is also referenced in the following:

Longevity Summit Dublin 2024

13-Jun-2024 to 16-Jun-2024

Event gathering Global Longevity and Rejuvenation community in Dublin by LEV Foundation (Dublin, Ireland)

Rejuvenation Startup Summit 2024

10-May-2024 to 11-May-2024

The leading networking event for rejuvenation startups, longevity investors and translational researchers by Forever Healthy Foundation

TransVision Madrid 2024

01-Oct-2024

World longevity congress organised by José Luis Cordeiro (Madrid, Spain, FREE)

YouthBio Therapeutics

Developing rejuvenation gene therapies based on partial reprogramming by Yamanaka factors

Alejandro Ocampo News

Common prescription medications can affect how long people live

Common prescription medications can affect how long people live

Live Forever Club - 11-Oct-2024

Metformin (HR 1.01, CI 0.95–1.07) had a neutral effect on mortality

Partial reprogramming rejuvenates the ageing mouse brain, improving memory

Partial reprogramming rejuvenates the ageing mouse brain, improving memory

Live Forever Club - 09-Aug-2024

This breakthrough offers hope for combating age-related cognitive decline

Reason reports back from Rejuvenation Startup Summit 2024

Reason reports back from Rejuvenation Startup Summit 2024

Fight Aging! - 13-May-2024

A great summary of 25 speakers who are in various stages of platform building, drug discovery and clinical trials

UK study finds 14 prescription meds possibly linked to longer life

UK study finds 14 prescription meds possibly linked to longer life

Lifespan.io (LEAF) - 15-Mar-2024

Viagra, cholesterol meds & estrogen replacements linked to longevity, but further research needed

Epiterna receives 10m euros to extend lifespans of pets and people

Epiterna receives 10m euros to extend lifespans of pets and people

Sifted - 01-Aug-2023

Planning to test its therapies in dogs next year, with human treatments expected in the near future

YouthBio Therapeutics unveils its board, with João Pedro de Magalhães as CSO

YouthBio Therapeutics unveils its board, with João Pedro de Magalhães as CSO

CISION PR Newswire - 14-Apr-2022

Another company enters the cellular reprogramming race - hopefully at least one will cross the finishing line

Anti-ageing breakthrough: Reprogramming the body could extend lifespan

Anti-ageing breakthrough: Reprogramming the body could extend lifespan

Independent - 15-Dec-2016

Previous attempts resulted in younger cells but the mice developed tumours. Salk Institute Salk ...